期刊文献+

肾母细胞瘤过表达基因促进肝癌细胞的侵袭与转移 被引量:1

Nephroblastoma overexpressed gene promotes migration and invasion of hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨肾母细胞瘤过表达基因(NOV CCN3)在肝癌中的表达及在肝癌侵袭中的作用。方法 :荧光定量PCR(realtime PCR)检测肝癌及癌旁组织中的CCN3的m RNA表达水平,同时检测肝癌细胞系及正常人肝细胞中CCN3的m RNA表达水平,Western blot检测肝癌及癌旁组织中CCN3蛋白的表达量;通过肝癌细胞过表达CCN3分析CCN3蛋白对肝癌细胞转移的作用;运用Transwell侵袭实验和划痕迁移实验研究CCN3过表达对肝癌细胞侵袭和迁移能力的影响。结果:50对样本中有39对CCN3的m RNA表达水平在肝癌组织中高于癌旁组织,Western blot提示肝癌组织中CCN3蛋白表达量高于癌旁组织。体外肝癌细胞的功能试验中,过表达CCN3能促进MHCC-97H、SMMC-7721细胞的侵袭与转移。结论:CCN3在肝癌组织中高表达,过表达CCN3能促进肝癌的侵袭与转移,CCN3发挥作用机制的研究能为肝细胞肝癌的治疗提供新的思路。 Objective:To detect the expression and study the role of nephroblastoma overexpressed gene(NOV CCN3)in hepatocelluar carcinoma(HCC). Methods:The expressions of CCN3 m RNA in HCC samples and cell lines were detected by real-time PCR,and the expressions of CCN3 protein in HCC tissues and adjacent non-cancer tissues were assessed by Western blot. In addition,invasion of HCC cells was observed after overexpressing CCN3 by Transwell invasion assay and wound healing assay. Results:In the total of 50 paired HCC specimens,compared with the adjacent non-cancer tissues,the expression of CCN3 m RNA was up-regulated in 39 cases,and the expression of CCN3 protein in HCC tissues was higher than that in adjacent non-cancer tissues. Overexpression of CCN3 enhanced HCC-derived MHCC-97 H,SMMC-7721 cellular invasion in vitro. Conclusion:This study indicates CCN3 is frequently overexpressed in hepatocellular carcinoma,and contributes to tumor cell invasion. The study of CCN3 may provide a novel therapeutic idea for prevention and treatment of invasion in HCC.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第8期1087-1091,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 卫生部医药发展项目(W2012Fz058)
关键词 CCN3 肝细胞肝癌 肿瘤侵袭 CCN3 hepatocellular carcinoma tumor invasion
  • 相关文献

参考文献13

  • 1Chun-Yin Huang,Chun-Yi Lee,Meng-Yi Chen,Hsiao-Chi Tsai,Horng-Chaung Hsu,Chih-Hsin Tang.Nephroblastoma overexpressed gene (NOV) enhances cell motility and COX-2 upregulation of human osteosarcoma involves αvβ5 integrin, ILK and AP-1-dependent pathways[J]. Biochemical Pharmacology . 2011 (5)
  • 2F.Xavier Bosch,Josepa Ribes,Mireia Díaz,Ramon Cléries.Primary liver cancer: Worldwide incidence and trends[J].Gastroenterology.2004(5)
  • 3Hiroshi Imamura,Yutaka Matsuyama,Eiji Tanaka,Takao Ohkubo,Kiyoshi Hasegawa,Shinichi Miyagawa,Yasuhiko Sugawara,Masami Minagawa,Tadatoshi Takayama,Seiji Kawasaki,Masatoshi Makuuchi.Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy[J]. Journal of Hepatology . 2002 (2)
  • 4Strong R W.Transplantation for liver and biliary cancer. Seminars in Surgical Oncology . 2000
  • 5Guo-Cai Li,Qing-Hai Ye,Qiong-Zhu Dong,Ning Ren,Hu-Liang Jia,Lun-Xiu Qin.TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model. Journal of Experimental & Clinical Cancer Research . 2012
  • 6Chen Po-Chun,Lin Tien-Huang,Cheng Hsu-Chen,Tang Chih-Hsin.CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis . 2012
  • 7Perbal B.NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Molecular pathology : MP . 2001
  • 8Perbal Bernard.The CCN3 protein and cancer. Advances in experimental medicine and biology . 2006
  • 9Perbal Bernard,Zuntini Monia,Zambelli Diana,Serra Massimo,Sciandra Marika,Cantiani Lara,Lucarelli Enrico,Picci Piero,Scotlandi Katia.Prognostic value of CCN3 in osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research . 2008
  • 10Maillard M,Cadot B,Ball R Y,Sethia K,Edwards D R,Perbal B,Tatoud R.Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Molecular pathology : MP . 2001

共引文献9

同被引文献21

  • 1He J,Gu D,Wu X,et al. Major causes of death among men and women in China [J]. N Engl J Med, 2005,353 (11):1124-1134.
  • 2Parkin DM,Bray FI,Devesa SS. Cancer burden in the year 2000. The global picture[J]. Eur J Cancer,2001,37 (Suppl 8 ) : S4-66.
  • 3Marelli L, Stigliano R,Triantos C, et al. Transarterial thera- py for hepatocellular carcinoma:which technique is more effective A systematic review of cohort and randomized studies [ J ]. Cardiovasc Intervent Radiol, 2006,30 ( 1 ) : 6- 25.
  • 4Tommasi S, Pinto R,Pilato B,et al. Molecular pathways and related target therapies in liver carcinoma [J]. Curr Pharm Des, 2007,13(32) : 3279-3287.
  • 5Hwang LH. Gene therapy strategies for hepatocellular car- cinoma[J]. J Biomed Sci,2006, 13(4):453-468.
  • 6Lee K,Yun ST,Kim YG,et al. Adeno-associated virus- mediated expression of apolipoprotein (a)kringles sup- presses hepatocellular carcinoma growth in mice [J]. Hepatology, 2006,43 (5) : 1063 - 1073.
  • 7Folkman J. Angiogenesis:an organizing principle for drug discovery [J ]. Nat Rev Drug Discov, 2007,6 (4) : 273-286.
  • 8Liu F,Tan G,Li J,et al. Gene transfer of endostatin en- hances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice [J]. Cancer Sci, 2007,98(9) : 1381-1387.
  • 9Graepler F,Verbeek B, Graeter T,et al. Combined endo- statin/sFlt-1 antiangiogenic gene therapy is highly effec- tive in a rat model of HCC[J]. Hepatology,2005,41 (4) : 879-886.
  • 10Asahara T, Masuda H,Takahashi T, et al. Bone marrow o- rigin of endothelial progenitor cells responsible for post- natal vasculogenesis in physiological and pathological neovascularization[J]. Circ Res,1999,85(3):221-228.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部